The Lactulose Solution, cataloged under National Stock Number 6505-01-708-8085, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Chartwell Rx Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-708-8085 |
| Primary Part Number | NDC62135-0003-47 |
| Item Name | Lactulose Solution |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Chartwell Rx Llc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 16.0 OUNCES OZ |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | DO NOT FREEZE AND CONTROLLED ROOM TEMPERATURE |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC62135-0003-47 PRIMARY | Chartwell Rx Llc (USA) |
| NDC83745-0405-16 PRIMARY | Apozeal Pharmaceuticals Inc Dba Apozeal Pharma (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM238992 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1649473 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-708-8085 is a Lactulose Solution, manufactured by Chartwell Rx Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-708-8085 has 2 manufacturer part numbers on file: NDC62135-0003-47 (Chartwell Rx Llc), NDC83745-0405-16 (Apozeal Pharmaceuticals Inc Dba Apozeal Pharma).
Key specifications for NDC62135-0003-47: Administration: ORAL; Primary Container Content Quantity: 16.0 OUNCES OZ; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.